B
HCAT icon

Bellecapital’s Health Catalyst HCAT Stock Holding History

Bellecapital’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-19,242
Closed -$225K – 178
2023
Q1 		$225K Sell
19,242
-510
-3% -$6.5K 0.06% 178
2022
Q4 		$210K Hold
19,752
– – 0.06% 180
2022
Q3 		$192K Sell
19,752
-2,268
-10% -$30K 0.06% 180
2022
Q2 		$319K Sell
22,020
-110,035
-83% -$1.88M 0.09% 147
2022
Q1 		$3.45M Buy
132,055
+11,753
+10% +$333K 1.09% 27
2021
Q4 		$4.77M Buy
120,302
+4,838
+4% +$220K 1.36% 23
2021
Q3 		$5.77M Buy
115,464
+3,117
+3% +$170K 1.76% 18
2021
Q2 		$6.24M Sell
112,347
-2,913
-3% -$155K 1.9% 17
2021
Q1 		$5.39M Buy
115,260
+13,322
+13% +$645K 1.68% 22
2020
Q4 		$4.44M Buy
+101,938
New +$3.76M 1.48% 22

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bellecapital's HCAT Position: Q2 2023 in Review

Bellecapital sold out of Health Catalyst (HCAT) in Q2 2023, closing a stake of 19,242 shares — an estimated $225K sold.

Bellecapital first reported a position in HCAT in Q4 2020 and held it in 10 quarters. The position peaked at $6.24M in Q2 2021. 154 funds tracked by Wall St. Rank hold HCAT as of Q2 2023.

  • Bellecapital reported no remaining Health Catalyst position as of Q2 2023 after selling out during the quarter.
  • Bellecapital sold 19,242 Health Catalyst shares in Q2 2023, an estimated $225K.
  • Bellecapital first reported a position in Health Catalyst in Q4 2020 and held it in 10 quarters.
  • Bellecapital's Health Catalyst position peaked at $6.24M in Q2 2021.
  • 154 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2023.

Based on Bellecapital's 13F filing for Q2 2023, filed 7 Jul 2023.